These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 22879465)

  • 1. Effectiveness of etanercept vs cyclophosphamide as treatment for patients with amyloid A amyloidosis secondary to rheumatoid arthritis.
    Nakamura T; Higashi S; Tomoda K; Tsukano M; Shono M
    Rheumatology (Oxford); 2012 Nov; 51(11):2064-9. PubMed ID: 22879465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis.
    Nakamura T; Higashi S; Tomoda K; Tsukano M; Baba S; Shono M
    Rheumatology (Oxford); 2006 Jan; 45(1):43-9. PubMed ID: 16219644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of etanercept in patients with AA amyloidosis secondary to rheumatoid arthritis.
    Nakamura T; Higashi S; Tomoda K; Tsukano M; Baba S
    Clin Exp Rheumatol; 2007; 25(4):518-22. PubMed ID: 17888205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical strategies for amyloid A amyloidosis secondary to rheumatoid arthritis.
    Nakamura T
    Mod Rheumatol; 2008; 18(2):109-18. PubMed ID: 18369528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of cyclophosphamide combined with prednisolone in patients with AA amyloidosis secondary to rheumatoid arthritis.
    Nakamura T; Yamamura Y; Tomoda K; Tsukano M; Shono M; Baba S
    Clin Rheumatol; 2003 Dec; 22(6):371-5. PubMed ID: 14677008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etanercept treatment of renal amyloidosis complicating rheumatoid arthritis.
    Smith GR; Tymms KE; Falk M
    Intern Med J; 2004; 34(9-10):570-2. PubMed ID: 15482271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-TNF therapy in renal amyloidosis in refractory rheumatoid arthritis: a new therapeutic perspective.
    Nobre CA; Callado MR; Rodrigues CE; de Menezes DB; Vieira WP
    Rev Bras Reumatol; 2010; 50(2):205-10. PubMed ID: 21125155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etanercept can induce resolution of renal deterioration in patients with amyloid A amyloidosis secondary to rheumatoid arthritis.
    Nakamura T; Higashi S; Tomoda K; Tsukano M; Shono M
    Clin Rheumatol; 2010 Dec; 29(12):1395-401. PubMed ID: 20440529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ageing: a risk factor for amyloid A amyloidosis in rheumatoid arthritis.
    Okuda Y; Yamada T; Matsuura M; Takasugi K; Goto M
    Amyloid; 2011 Sep; 18(3):108-11. PubMed ID: 21627560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of etanercept in amyloidosis secondary to rheumatoid arthritis, a report of two cases].
    Macías Fernández I; Fernández Rodríguez AM; García Pérez S
    Reumatol Clin; 2011; 7(6):397-400. PubMed ID: 22078699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy.
    Gottenberg JE; Merle-Vincent F; Bentaberry F; Allanore Y; Berenbaum F; Fautrel B; Combe B; Durbach A; Sibilia J; Dougados M; Mariette X
    Arthritis Rheum; 2003 Jul; 48(7):2019-24. PubMed ID: 12847696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment with cyclophosphamide and prednisolone can induce remission of nephrotic syndrome in a patient with renal amyloidosis, associated with rheumatoid arthritis.
    Maezawa A; Hiromura K; Mitsuhashi H; Tsukada Y; Kanai H; Yano S; Naruse T
    Clin Nephrol; 1994 Jul; 42(1):30-2. PubMed ID: 7923963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abdominal fat aspiration biopsy and genotyping of serum amyloid A contribute to early diagnosis of reactive AA amyloidosis secondary to rheumatoid arthritis.
    Ishii W; Matsuda M; Nakamura A; Nakamura N; Suzuki A; Ikeda S
    Intern Med; 2003 Sep; 42(9):800-5. PubMed ID: 14518665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
    Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
    Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Beneficial effect of salazosulfapyridine (SASP) in a patient with secondary renal amyloidosis].
    Hidaka M; Ohsawa I; Endo M; Fujita T; Ohi H; Kanmatsuse K; Kusumi Y; Yamaguchi Y
    Nihon Jinzo Gakkai Shi; 1998 Sep; 40(7):555-9. PubMed ID: 9805922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis.
    Moriguchi M; Terai C; Koseki Y; Uesato M; Nakajima A; Inada S; Nishinarita M; Uchida S; Nakajima A; Kim SY; Chen CL; Kamatani N
    Hum Genet; 1999 Oct; 105(4):360-6. PubMed ID: 10543406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Serum Amyloid A (SAA1) and SAA2 gene polymorphisms on renal amyloidosis, and on SAA/C-reactive protein values in patients with familial mediterranean fever in the Turkish population.
    Bakkaloglu A; Duzova A; Ozen S; Balci B; Besbas N; Topaloglu R; Ozaltin F; Yilmaz E
    J Rheumatol; 2004 Jun; 31(6):1139-42. PubMed ID: 15170927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission of proteinuria and preservation of renal function in patients with renal AA amyloidosis secondary to rheumatoid arthritis.
    Ueno T; Takeda K; Nagata M
    Nephrol Dial Transplant; 2012 Feb; 27(2):633-9. PubMed ID: 21771754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective anti-TNF-alpha therapy can induce rapid resolution and sustained decrease of gastroduodenal mucosal amyloid deposits in reactive amyloidosis associated with rheumatoid arthritis.
    Kuroda T; Wada Y; Kobayashi D; Murakami S; Sakai T; Hirose S; Tanabe N; Saeki T; Nakano M; Narita I
    J Rheumatol; 2009 Nov; 36(11):2409-15. PubMed ID: 19797512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results, principles and pitfalls in the management of renal AA-amyloidosis; a 10-21 year followup of 16 patients with rheumatic disease treated with alkylating cytostatics.
    Berglund K; Thysell H; Keller C
    J Rheumatol; 1993 Dec; 20(12):2051-7. PubMed ID: 8014932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.